2023
DOI: 10.1080/10717544.2022.2162156
|View full text |Cite
|
Sign up to set email alerts
|

The development and evaluation of hyaluronic acid coated mitochondrial targeting liposomes for celastrol delivery

Abstract: In order to precisely deliver celastrol into mitochondria of tumor cells, improve antitumor efficacy of celastrol and overcome its troublesome problems in clinical application, a novel multistage-targeted celastrol delivery system (C-TL/HA) was developed via electrostatic binding of hyaluronic acid (HA) to celastrol-loaded cationic liposomes composed of natural soybean phosphatidylcholine and cholesterol modified with mitochondrial targeting molecular TPP. Study results in this article showed that C-TL/HA succ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(2 citation statements)
references
References 30 publications
0
2
0
Order By: Relevance
“…Recently, researchers have increasingly focused on the role of celastrol in weight loss through multiple pathway (e.g., leptin sensitivity, energy expenditure, and appetite control). However, the potential for the clinical use of celastrol is largely limited by its toxicity and poor water solubility. Fortunately, several pharmaceutic strategies have been developed to circumvent these problems, including liposomes, nanoencapsulation, polymer drugs, and polymeric micelles. , Various celastrol-loaded carriers greatly improve the bioavailability of celastrol and significantly reduce the adverse reactions of drugs. …”
Section: Introductionmentioning
confidence: 99%
“…Recently, researchers have increasingly focused on the role of celastrol in weight loss through multiple pathway (e.g., leptin sensitivity, energy expenditure, and appetite control). However, the potential for the clinical use of celastrol is largely limited by its toxicity and poor water solubility. Fortunately, several pharmaceutic strategies have been developed to circumvent these problems, including liposomes, nanoencapsulation, polymer drugs, and polymeric micelles. , Various celastrol-loaded carriers greatly improve the bioavailability of celastrol and significantly reduce the adverse reactions of drugs. …”
Section: Introductionmentioning
confidence: 99%
“…21 Liposomes have been used for celastrol delivery by incorporating TPP-modified cholesterol with natural soy phosphatidylcholine, paving the way for the clinical application of triptolide in tumor therapy. 22 Furthermore, researchers have successfully developed novel fluorescent carbon dots with intrinsic mitochondrial targeting capabilities, by employing a one-step hydrothermal treatment of mercaptosuccinic acid, ethylenediamine, and chitosan. 23 The resulting carbon dots enable mitochondrial imaging and photodynamic cancer therapy specifically targeting mitochondria.…”
mentioning
confidence: 99%